REGEN BIOPHARMA, INC. Proceeds from Notes Payable
REGEN BIOPHARMA, INC. (RGBP) reported Proceeds from Notes Payable of $149.63 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-12-30
- REGEN BIOPHARMA, INC. proceeds from notes payable for the quarter ending 2025-09-30 was -$75.00K.
- REGEN BIOPHARMA, INC. proceeds from notes payable for fiscal 2025 was $149.63K, a 93.09% increase from fiscal 2024.
- REGEN BIOPHARMA, INC. proceeds from notes payable for fiscal 2024 was $77.49K, a 68.21% decline from fiscal 2023.
- REGEN BIOPHARMA, INC. proceeds from notes payable for fiscal 2023 was $243.75K, a 48747.70% increase from fiscal 2022.
- REGEN BIOPHARMA, INC. proceeds from notes payable for fiscal 2022 was $499.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2025-09-30 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-30 | $149.63K 10-K · filed 2025-12-30 | |
| 2025-06-30 | $224.63K 10-Q · filed 2025-08-11 | ||
| 2024-09-30 | $77.49K 10-K · filed 2025-05-13 | ||
| 2023-09-30 | $243.75K 10-K · filed 2025-05-13 | ||
| 2022-09-30 | $499.00 10-K · filed 2023-11-20 |